IAM Media's latest weekly dispatch bundles five intellectual-property stories that R&D managers and licensing leads should track: an interview with the head of technology transfer at the US National Institutes of Health, commercial traction for Avanci's vehicle licensing program, a CEO interview at IPValue, the release of the Patent 1000 rankings, and an intervention by Squires in the Nokia v Asus dispute.

Each item carries direct operational weight for research organizations.

NIH technology transfer. The interview with NIH's tech transfer head lands at a moment when federal agencies face mounting pressure to account for licensing revenue and downstream impact of publicly funded inventions. For university and institute TTOs, NIH's approach to exclusive versus non-exclusive licensing of intramural inventions remains a benchmark. Managers negotiating materials-transfer and patent agreements with NIH investigators will want the full interview's specifics, which the headline alone does not disclose — the piece sits behind IAM's paywall.

Avanci commercial vehicles. Avanci, the independent pool for cellular standard-essential patents, is reporting traction in its commercial-vehicle licensing program. For automotive R&D and procurement teams, pool participation determines per-vehicle royalty exposure and supplier indemnity terms. IAM's coverage indicates uptake among fleet and truck makers, though the headline does not specify which manufacturers signed or at what rates — numbers that materially affect build costs for connected-vehicle programs.

IPValue strategy. The CEO interview at IPValue signals how one of the larger patent-buying and monetization firms is positioning itself. IPValue historically acquires portfolios from large corporates and monetizes them through licensing campaigns. R&D directors at companies with dormant patent estates should read the interview for signals on which technology sectors command acquisition premium — the headline does not segment them.

Patent 1000 released. IAM has published the newest edition of its Patent 1000, the annual directory ranking firms and individual attorneys across jurisdictions. The release functions as a procurement tool: R&D-heavy organizations use it to shortlist outside counsel for filing, opposition and litigation work. Rankings cover prosecution and contention practices by country; firms omitted from a jurisdiction's list face a harder sell for portfolio work.

Squires in Nokia v Asus. Squires has intervened in Nokia v Asus, the ongoing dispute between the Finnish telecom giant and the Taiwanese electronics maker. The intervention adds a third-party interest — likely amicus or equity-style backing, though the dispatch headline does not state the capacity — to a case that could clarify leverage available to licensors of standard-essential patents in consumer electronics. Litigation-avoidance budgeting at device makers depends on how such precedents shake out; the underlying IAM article carries the procedural detail.

The five items share a throughline: licensing infrastructure — pools, rankings, agency practices, litigation finance — now shapes portfolio decisions as much as patent quality itself.

The full dispatch, with the NIH and IPValue interviews and the Nokia v Asus procedural record, is available through IAM Media.